Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesco Lo-Coco

Showing results (131-140 of 204) with videos related to

Pageof 21
Sort By:
Cancer|November 15, 2005
The addition of rituximab to fludarabine improves clinical outcome in untreated patients with ZAP-70-negative chronic lymphocytic leukemiaGiovanni Del Poeta, Maria Ilaria Del Principe, Maria Antonietta Irno Consalvo, et al.
Haematologica|September 14, 2019
Obesity is a risk factor for acute promyelocytic leukemia: evidence from population and cross-sectional studies and correlation with FLT3 mutations and polyunsaturated fatty acid metabolismLuca Mazzarella, Edoardo Botteri, Anthony Matthews, et al.
Haematologica|April 30, 2008
Early prediction of treatment outcome in acute myeloid leukemia by measurement of WT1 transcript levels in peripheral blood samples collected after chemotherapyDaniela Cilloni, Francesca Messa, Francesca Arruga, et al.
Oncotarget|November 16, 2017
The forkhead box C1 (FOXC1) transcription factor is downregulated in acute promyelocytic leukemiaEmiliano Fabiani, Giulia Falconi, Nélida Inés Noguera, et al.
Blood|June 25, 2009
Identification of patients with poorer survival in primary myelofibrosis based on the burden of JAK2V617F mutated allelePaola Guglielmelli, Giovanni Barosi, Giorgina Specchia, et al.
Blood Advances|December 14, 2019
Retinoic acid synergizes with the unfolded protein response and oxidative stress to induce cell death in FLT3-ITD+ AMLSilvia Masciarelli, Ernestina Capuano, Tiziana Ottone, et al.
Cancers|September 19, 2019
Cytotoxicity and Differentiating Effect of the Poly(ADP-Ribose) Polymerase Inhibitor Olaparib in Myelodysplastic SyndromesIsabella Faraoni, Maria Irno Consalvo, Francesca Aloisio, et al.
Annals of Hematology|September 5, 2014
Acute promyelocytic leukemia in patients aged >70 years: the cure beyond the agePaola Finsinger, Massimo Breccia, Clara Minotti, et al.
Genes, Chromosomes & Cancer|November 22, 2008
Identification of a potential "hotspot" DNA region in the RUNX1 gene targeted by mitoxantrone in therapy-related acute myeloid leukemia with t(16;21) translocationTiziana Ottone, Syed Khizer Hasan, Enrico Montefusco, et al.
Blood|June 12, 2010
A monoclonal antibody against mutated nucleophosmin 1 for the molecular diagnosis of acute myeloid leukemiasAlicja M Gruszka, Serena Lavorgna, Maria Irno Consalvo, et al.
Pageof 21

Showing results (131-140 of 204) with videos related to

Sort By:
Pageof 21
Cancer|November 15, 2005
The addition of rituximab to fludarabine improves clinical outcome in untreated patients with ZAP-70-negative chronic lymphocytic leukemiaGiovanni Del Poeta, Maria Ilaria Del Principe, Maria Antonietta Irno Consalvo, et al.
Haematologica|September 14, 2019
Obesity is a risk factor for acute promyelocytic leukemia: evidence from population and cross-sectional studies and correlation with FLT3 mutations and polyunsaturated fatty acid metabolismLuca Mazzarella, Edoardo Botteri, Anthony Matthews, et al.
Haematologica|April 30, 2008
Early prediction of treatment outcome in acute myeloid leukemia by measurement of WT1 transcript levels in peripheral blood samples collected after chemotherapyDaniela Cilloni, Francesca Messa, Francesca Arruga, et al.
Oncotarget|November 16, 2017
The forkhead box C1 (FOXC1) transcription factor is downregulated in acute promyelocytic leukemiaEmiliano Fabiani, Giulia Falconi, Nélida Inés Noguera, et al.
Blood|June 25, 2009
Identification of patients with poorer survival in primary myelofibrosis based on the burden of JAK2V617F mutated allelePaola Guglielmelli, Giovanni Barosi, Giorgina Specchia, et al.
Blood Advances|December 14, 2019
Retinoic acid synergizes with the unfolded protein response and oxidative stress to induce cell death in FLT3-ITD+ AMLSilvia Masciarelli, Ernestina Capuano, Tiziana Ottone, et al.
Cancers|September 19, 2019
Cytotoxicity and Differentiating Effect of the Poly(ADP-Ribose) Polymerase Inhibitor Olaparib in Myelodysplastic SyndromesIsabella Faraoni, Maria Irno Consalvo, Francesca Aloisio, et al.
Annals of Hematology|September 5, 2014
Acute promyelocytic leukemia in patients aged >70 years: the cure beyond the agePaola Finsinger, Massimo Breccia, Clara Minotti, et al.
Genes, Chromosomes & Cancer|November 22, 2008
Identification of a potential "hotspot" DNA region in the RUNX1 gene targeted by mitoxantrone in therapy-related acute myeloid leukemia with t(16;21) translocationTiziana Ottone, Syed Khizer Hasan, Enrico Montefusco, et al.
Blood|June 12, 2010
A monoclonal antibody against mutated nucleophosmin 1 for the molecular diagnosis of acute myeloid leukemiasAlicja M Gruszka, Serena Lavorgna, Maria Irno Consalvo, et al.
Pageof 21